Sensus Healthcare, Inc. (NASDAQ:SRTS) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET
Company Participants
Kim Golodetz - Senior Vice President and Principal, Lippert/Heilshorn & Associates Inc.
Joe Sardano - Chairman & Chief Executive Officer
Javier Rampolla - Chief Financial Officer
Conference Call Participants
Scott Henry - ROTH Capital
Anthony Vendetti - Maxim Group
Operator
Good day ladies and gentlemen and welcome to the Sensus Healthcare Second Quarter 2022 Earnings Conference Call. [Operator Instructions]
At this time, it is my pleasure to turn the floor over to your host, Kim Golodetz. Ma'am, the floor is yours.
Kim Golodetz
Thank you. This is Kim Golodetz with LHA. Thank you all for participating in today's call. Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, President and General Counsel; and Javier Rampolla, Chief Financial Officer.
As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities laws. All statements other than historical facts that address activities Sensus Healthcare assumes, plans, expects, believes, intends or anticipates and other similar expressions will, should or may occur in the future are forward-looking statements. The forward-looking statements are management's beliefs based on currently available information as of the date of this conference call, August 4, 2022. Sensus Healthcare undertakes no obligation to update or revise any forward-looking statements, except as required by law. All forward-looking statements are subject to risks and uncertainties, including the continuation and severity of the COVID-19 pandemic and its impact on sales and marketing, as described in the company's forms 10-K and 10-Q.
During today's call, there will also be reference to certain non-GAAP financial measures. Sensus believes these measures provide useful information for investors, yet should not be considered as a substitute for GAAP nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in today's financial results press release.
With that said, I'd like to turn the call over to Joe Sardano. Joe?
Joe Sardano
Thank you, Kim and good afternoon, everyone. I'm delighted to be reporting on another quarter of strong financial performance with significant year-over-year revenue growth and continued profitability. Our revenue of $12.1 million was more than double last year's Q2 revenue. In addition, we earned $0.21 a share compared with $0.20 from continuing operations in the first quarter of this year and a loss of $0.02 last year.